207 related articles for article (PubMed ID: 21871654)
1. A multiinstitutional study of the effects of medical therapy for lower urinary symptoms on the perioperative outcomes of holmium laser enucleation of the prostate.
Warner JN; Nunez RN; Tyson MD; Viprakasit DP; Miller NL; Humphreys MR
Urology; 2011 Dec; 78(6):1385-90. PubMed ID: 21871654
[TBL] [Abstract][Full Text] [Related]
2. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.
Jaeger CD; Krambeck AE
Urology; 2013 May; 81(5):1025-9. PubMed ID: 23465142
[TBL] [Abstract][Full Text] [Related]
3. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
[TBL] [Abstract][Full Text] [Related]
4. Holmium laser ablation and enucleation of the prostate: a pilot study of the hybrid technique.
Helfand BT; Manvar AM; Auffenberg GB; Blackwell R; Hartman RJ; McVary KT
Can J Urol; 2010 Jun; 17(3):5190-4. PubMed ID: 20566012
[TBL] [Abstract][Full Text] [Related]
5. Progression of lower urinary tract symptoms after discontinuation of 1 medication from 2-year combined alpha-blocker and 5-alpha-reductase inhibitor therapy for benign prostatic hyperplasia in men--a randomized multicenter study.
Lin VC; Liao CH; Kuo HC
Urology; 2014 Feb; 83(2):416-21. PubMed ID: 24332123
[TBL] [Abstract][Full Text] [Related]
6. Holmium laser enucleation of the prostate--outcomes independent of prostate size?
Humphreys MR; Miller NL; Handa SE; Terry C; Munch LC; Lingeman JE
J Urol; 2008 Dec; 180(6):2431-5; discussion 2435. PubMed ID: 18930490
[TBL] [Abstract][Full Text] [Related]
7. Early symptom improvement and discontinuation of 5-α-reductase inhibitor (5ARI) therapy in patients with benign prostatic hyperplasia (BPH).
Kruep EJ; Phillips E; Hogue S; Eaddy M
Ann Pharmacother; 2014 Mar; 48(3):343-8. PubMed ID: 24311727
[TBL] [Abstract][Full Text] [Related]
8. Impact of medical therapy on transurethral resection of the prostate: two decades of change.
Izard J; Nickel JC
BJU Int; 2011 Jul; 108(1):89-93. PubMed ID: 20883490
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification for benign prostatic hyperplasia (BPH) treatment.
Emberton M; Fitzpatrick JM; Rees J
BJU Int; 2011 Mar; 107(6):876-80. PubMed ID: 21265993
[TBL] [Abstract][Full Text] [Related]
10. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
11. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
12. Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement.
Suardi N; Scattoni V; Briganti A; Salonia A; Naspro R; Gallina A; Cestari A; Colombo R; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
Eur Urol; 2008 Jun; 53(6):1180-5. PubMed ID: 17659829
[TBL] [Abstract][Full Text] [Related]
13. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
[TBL] [Abstract][Full Text] [Related]
14. Influence of prostate size on the outcome of holmium laser enucleation of the prostate.
Shah HN; Sodha HS; Kharodawala SJ; Khandkar AA; Hegde SS; Bansal MB
BJU Int; 2008 Jun; 101(12):1536-41. PubMed ID: 18218057
[TBL] [Abstract][Full Text] [Related]
15. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients.
Kuntz RM; Ahyai S; Lehrich K; Fayad A
J Urol; 2004 Sep; 172(3):1012-6. PubMed ID: 15311026
[TBL] [Abstract][Full Text] [Related]
16. Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial.
Aho TF; Gilling PJ; Kennett KM; Westenberg AM; Fraundorfer MR; Frampton CM
J Urol; 2005 Jul; 174(1):210-4. PubMed ID: 15947629
[TBL] [Abstract][Full Text] [Related]
17. Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome.
Suardi N; Gallina A; Salonia A; Briganti A; Dehò F; Zanni G; Abdollah F; Naspro R; Cestari A; Guazzoni G; Rigatti P; Montorsi F
Curr Opin Urol; 2009 Jan; 19(1):38-43. PubMed ID: 19057214
[TBL] [Abstract][Full Text] [Related]
18. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center.
Zhang F; Shao Q; Herrmann TR; Tian Y; Zhang Y
Urology; 2012 Apr; 79(4):869-74. PubMed ID: 22342411
[TBL] [Abstract][Full Text] [Related]
19. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
[TBL] [Abstract][Full Text] [Related]
20. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.
Wilson LC; Gilling PJ; Williams A; Kennett KM; Frampton CM; Westenberg AM; Fraundorfer MR
Eur Urol; 2006 Sep; 50(3):569-73. PubMed ID: 16704894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
